Skip to main content

Tweets

NOR-DRUM Study: TNF Inhibitor Therapeutic Drug Monitoring is Effective https://t.co/RPS6OiXsx2 #ACR21 https://t.co/uMv5LNq3Sh
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
Sign up today to receive #ACR21 news and select topic emails throughout the conference. #RheumNow https://t.co/riyAnrRHhX https://t.co/IEjvmn7glF
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
Rituximab Patients May Benefit from Third COVID-19 Vaccine Dose This abstract will be presented at 10:45am EST, Tuesday, November 9, 2021 during the Late-Breaking Abstracts session (L16 - L21). #ACR21 https://t.co/A1nAL8OnCu https://t.co/lsSyZmjfuF
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
#ClinicalPearl Distal fingers in #Scleroderma lose pulp. In this patient #calcinosis (chronic) caused the nail/bed to expand! @RheumNow @CRASCRRheum https://t.co/bj4cxP7q6J
Janet Pope @Janetbirdope ( View Tweet )
4 years 9 months ago
I like this. Downloaded and read. Great for patients too! https://t.co/B081u0ijjU

Dr. John Cush @RheumNow ( View Tweet )

4 years 9 months ago
Survey of 10,234 Dannish Primary Care pts (w/ LBP, hip or knee #OA)to Dx self reported Lumbar Spinal Stenosis (LSS) based on 11 Sxs. LSS Sxs were more in LBP (11–71%) than hip (11–50%) or knee OA (8–40%). Overall LSS seen <10% cohorts https://t.co/v9LO09IZla

Dr. John Cush @RheumNow ( View Tweet )

4 years 9 months ago
But baricitinib inhibits endocytosis of the virus and thus should be antiviral early in the disease. I believe the paradox is based on who gets bari, mostly those with poorly controlled disease https://t.co/euOthMLDt3

Dr. John Cush @RheumNow ( View Tweet )

4 years 9 months ago
1119 thoracic aortic surgeries - 3.7% dx as inflammatory aortitis (66% CIA, 27% GCA, 5% TAK) (20% given steroids). Aortitis were more female, older, more HTN w/ more immunosuppressives, but no diff in 30d mortality (7.3 vs 6.5%) https://t.co/94VBaRAry5

Dr. John Cush @RheumNow ( View Tweet )

4 years 9 months ago
Happy Diwali to all my Twitter friends. May this festival of light glow your life with knowledge, happiness and prosperity. I also feel for all those who lost their loved one this year to Covid and may Diwali brings peace to you as well. https://t.co/xRGnuxz068
Rohit Aggarwal @docrota ( View Tweet )
4 years 9 months ago
CRESPA trial pts (Golimumab in monoRx peripheral SpA) offered change to MTX. 25/60 pSpA entered the step-down to MTX, but 21/25 flared & 4 (16%) stayed in remission (others restarted GOL). MTX cant maintain GOL remission in pSpA https://t.co/zGg3UqoDqp

Dr. John Cush @RheumNow ( View Tweet )

4 years 9 months ago
Drug development in the USA: Did you know? 1. Typical drug development timeline is 10-15 years; 2. It cost as much as US $2.6 billion to bring a drug to market; 3. Only 0.02% of drugs in development make it to market https://t.co/GXKddBLOUv

Dr. John Cush @RheumNow ( View Tweet )

4 years 9 months ago
Management of Immune-Related Adverse Events - ASCO Guideline https://t.co/6G8WT7ijlL #ACR21 https://t.co/lfslvXbUQs
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
×